EUVIMEDEUVIMED entdecken
Crossref

Risk Factors and Prediction Model for False Negative Results in Repeated EUS-FNA/B of Pancreatic Solid Lesions

J Ma, W Jiang, K Wang, Z Jin

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S580

DOI: 10.1055/s-0046-1821733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von J Ma und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Repeat endoscopic ultrasound-guided fine-needle aspiration/biopsy (rEUS-FNA/B) is recommended in solid pancreatic lesions (SPLs) with inconclusive initial results. However, even rEUS-FNA/B cannot completely eliminate false negatives in challenging cases. This study aims to identify risk factors of false-negative results in rEUS-FNA/B and develop a prediction model.

Methods

Data of patients who had initial inconclusive diagnosis and underwent rEUS-FNA/B for SPLs across eight Chinese medical centers from January 2013 to June 2024 were retrospectively reviewed. Logistic regression was performed to identify the risk factors of false-negative results in rEUS-FNA/B. A clinical prediction model using random forest (RF) algorithm was developed with leave-one-hospital-out cross validation [ 1 ].

Results

A total of 230 patients were enrolled in this study. Among them,159 patients (69.1%) were diagnosed with malignancies, while 71 patients (30.8%) had benign lesions. The diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of rEUS-FNA were 75.00%, 62.63%, 100%, 100%, and 56.98%, respectively, whereas those of rEUS-FNB were 84.15%, 78.33%, 100%, 100%, and 62.86%. At multivariate analysis, lesion size 20-40mm (OR 0.26), lesion size≥40mm (OR 0.20),≤2 needle passes (OR 3.1), no liquid-based cytology (LBC) examination (OR 3.95) were found to be independently associated with false-negative results. A final RF model with 4 features (lesion size, rEUS-FNA/B needle type, LBC, smear cytology) showed moderate ability to distinguish false-negative results in both training (AUC=0.78) and validation sets (AUC=0.68).

Conclusions

To minimize false-negative outcomes during rEUS-FNA/B, LBC is strongly recommended. Additionally, SPLs with a maximum diameter of≤20 mm exhibit a higher probability for producing false-negative results during rEUS-FNA/B procedures. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Ma, J., Jiang, W., Wang, K., & Jin, Z. (2026). Risk Factors and Prediction Model for False Negative Results in Repeated EUS-FNA/B of Pancreatic Solid Lesions. Endoscopy, 58(S 03 S 03), S580. https://doi.org/10.1055/s-0046-1821733

Vancouver

Ma J, Jiang W, Wang K, Jin Z. Risk Factors and Prediction Model for False Negative Results in Repeated EUS-FNA/B of Pancreatic Solid Lesions. Endoscopy. 2026;58(S 03 S 03):S580. doi:10.1055/s-0046-1821733

BibTeX
@article{Ma2026,
  author = {Ma, J and Jiang, W and Wang, K and Jin, Z},
  title = {Risk Factors and Prediction Model for False Negative Results in Repeated EUS-FNA/B of Pancreatic Solid Lesions},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S580},
  doi = {10.1055/s-0046-1821733}
}
Kostenlos starten →